Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: J Immunol. 2011 Jun 24;187(3):1393–1402. doi: 10.4049/jimmunol.1100980

TABLE I. ML1419c 9mer, 15mer and 30mer peptides.

Peptide amino acid sequence HLA-A*0201 binding affinity (IC50)* in vivo CTL induction
ML1419c p113–121 RLDGTTLEV 0.035 μM ++
ML1419c p108–122 EAVLLRLDGTTLEVE > 50 μM +
ML1419c p100-129 VGDASQPS EAVLLRLDGTTLEVEAVSVLTV > 50 μM +
Rv1886 p143-152 FIYAGSLSAL 0.01 μM -
*

Peptide binding affinity (IC50) was defined as high-affinity (< 1 μM), intermediate-affinity (1 μM to 10 μM), weak-affinity (10 μM to 100 μM), or nonbinding (>100 μM), according to reference (46).